Completed PHASE1 INTERVENTIONAL 2-arm NCT03980691

Effect of Chidamide Combined With CAT-T or TCR-T Cell Therapy on HIV-1 Latent Reservoir

Sponsor: Guangzhou 8th People's Hospital

Conditions HIV/AIDS

Interventions Chidamide with CAR-T or TCR-T cell therapy

Updated 5 times since 2019 Last updated: Jul 19, 2021 Started: Dec 1, 2017 Primary completion: May 31, 2020 Completion: May 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates HIV/AIDS and is currently completed. Guangzhou 8th People's Hospital leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Sep 2021 — Jul 2024 [monthly]

Completed PHASE1

Status: Recruiting → Completed
Jan 2021 — Sep 2021 [monthly]

Recruiting PHASE1
Jul 2019 — Jan 2021 [monthly]

Recruiting PHASE1

First recorded

Dec 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Guangzhou 8th People's Hospital
Sun Yat-sen University

Data source: Guangzhou 8th People's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China